119 related articles for article (PubMed ID: 15320959)
21. Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo.
Moriya F; Ogasawara S; Basaki Y; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Nishida N; Matsuoka K; Kojiro M; Kuwano M; Yano H
Int J Oncol; 2008 Oct; 33(4):647-55. PubMed ID: 18813777
[TBL] [Abstract][Full Text] [Related]
22. Interferon Gamma-Inducible Protein 16 of Peripheral Blood Mononuclear Cells May Sense Hepatitis B Virus Infection and Regulate the Antiviral Immunity.
Lu YQ; Wu J; Wu XJ; Ma H; Ma YX; Zhang R; Su MN; Wu N; Chen GY; Chen HS; Pan XB
Front Cell Infect Microbiol; 2021; 11():790036. PubMed ID: 34869083
[TBL] [Abstract][Full Text] [Related]
23. Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers.
Barril G; Quiroga JA; Sanz P; Rodrìguez-Salvanés F; Selgas R; Carreño V
Aliment Pharmacol Ther; 2004 Jul; 20(1):37-44. PubMed ID: 15225169
[TBL] [Abstract][Full Text] [Related]
24. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.
Kim KI; Kim SR; Sasase N; Taniguchi M; Harada S; Kinoshita K; Kim SH; Akimoto Y; Shikata M; Kimura N; Izawa S; Ohtani A; Nakao K; Motojima M; Kinoshita M; Hirai M; Ohzu M; Hirooka T; Nabeshima S; Ishii F; Tanaka K; Hotta H
J Clin Pharm Ther; 2006 Oct; 31(5):441-6. PubMed ID: 16958821
[TBL] [Abstract][Full Text] [Related]
25. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.
Chang CH; Rossi EA; Cardillo TM; Nordstrom DL; McBride WJ; Goldenberg DM
Bioconjug Chem; 2009 Oct; 20(10):1899-907. PubMed ID: 19736932
[TBL] [Abstract][Full Text] [Related]
26. Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.
Ichikawa T; Nakao K; Nakata K; Yamashita M; Hamasaki K; Shigeno M; Abiru S; Ishikawa H; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2002 Jun; 294(2):414-22. PubMed ID: 12051728
[TBL] [Abstract][Full Text] [Related]
27. Modulation of double-stranded RNA-mediated gene induction by interferon in human umbilical vein endothelial cells.
Harcourt JL; Hagan MK; Offermann MK
J Interferon Cytokine Res; 2000 Nov; 20(11):1007-13. PubMed ID: 11096458
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA.
McNair AN; Cheng D; Monjardino J; Thomas HC; Kerr IM
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1371-8. PubMed ID: 7911507
[TBL] [Abstract][Full Text] [Related]
29. Induction of collagenase mRNA expression in dermal fibroblasts by IFN-alpha 2b and determination of the IFN-alpha 2b responsive element on 5'-flanking regions of collagenase promoter.
Ghahary A; Tredget EE; Shen Q
J Interferon Cytokine Res; 2001 Aug; 21(8):611-20. PubMed ID: 11559439
[TBL] [Abstract][Full Text] [Related]
30. Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.
Glue P; Fang JW; Rouzier-Panis R; Raffanel C; Sabo R; Gupta SK; Salfi M; Jacobs S
Clin Pharmacol Ther; 2000 Nov; 68(5):556-67. PubMed ID: 11103758
[TBL] [Abstract][Full Text] [Related]
31. Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy.
Tateno M; Honda M; Kawamura T; Honda H; Kaneko S
J Infect Dis; 2007 Jan; 195(2):255-67. PubMed ID: 17191171
[TBL] [Abstract][Full Text] [Related]
32. Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: a vicious circle of clinical significance?
Franceschini L; Realdon S; Marcolongo M; Mirandola S; Bortoletto G; Alberti A
Hepatology; 2011 Aug; 54(2):484-94. PubMed ID: 21538438
[TBL] [Abstract][Full Text] [Related]
33. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
[TBL] [Abstract][Full Text] [Related]
34. Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.
Derbala M; Amer A; Bener A; Lopez AC; Omar M; El Ghannam M
J Viral Hepat; 2005 Jul; 12(4):380-5. PubMed ID: 15985008
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection.
Jara P; Hierro L; de la Vega A; Díaz C; Camarena C; Frauca E; Miños-Bartolo G; Díez-Dorado R; de Guevara CL; Larrauri J; Rueda M
Pediatr Infect Dis J; 2008 Feb; 27(2):142-8. PubMed ID: 18174875
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
Napoli N; Giannelli G; Parisi CV; Antonaci A; Maddalena G; Antonaci S
New Microbiol; 2005 Jan; 28(1):13-21. PubMed ID: 15782622
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.
Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C
Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916
[TBL] [Abstract][Full Text] [Related]
38. Detection and characterization of antibodies to PEG-IFN-alpha2b using surface plasmon resonance.
Takacs MA; Jacobs SJ; Bordens RM; Swanson SJ
J Interferon Cytokine Res; 1999 Jul; 19(7):781-9. PubMed ID: 10454349
[TBL] [Abstract][Full Text] [Related]
39. Poly I:CLC induction of the interferon system in mice: an initial study of four detection methods.
Poast J; Seidel HM; Hendricks MD; Haslam JA; Levy HB; Baron S
J Interferon Cytokine Res; 2002 Oct; 22(10):1035-40. PubMed ID: 12433283
[TBL] [Abstract][Full Text] [Related]
40. Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C.
Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Garcia A; Moore PA; Yu R; Subramanian GM
Antivir Ther; 2006; 11(7):901-8. PubMed ID: 17302252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
